Advisory Board and Editors Pharmacology

Journal Factsheet
A one-page PDF to help when considering journal options with co-authors
Download Factsheet
I told my colleagues that PeerJ is a journal where they need to publish if they want their paper to be published quickly and with the strict peer review expected from a good journal.
Sohath Vanegas,
PeerJ Author
View author feedback

Mirela Sedic

Dr Mirela Sedic (born Bauman) is Principal Scientist at the Institute for Anthropological Research Zagreb. She has authored over 50 scientific publications in peer-reviewed journals including high-impact journals such as BBA Molecular Basis of Disease, Molecular Cancer, The Journal of Pathology, Molecular Cancer Therapeutics, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Cancer Treatment Reviews.

She was the co-PI of international collaborative project with Functional Genomics Center Zurich in Switzerland (PRIME-XS-0000184 Proteomic profiling of retinal proteins from rat model of age-related macular degeneration 2012-2014) and the PI of the University of Rijeka grant “Screening and biological evaluation of acid ceramidase and sphingosine kinase inhibitors as a new class of anti-tumour agents” (2014 – 2017). She is currently the PI of the project funded by the Croatian Science Foundation “Dissecting the mechanisms of therapy resistance in BRAF-mutant colon cancer using an integrated –omics approach” (2019 – 2023) and the PI of the University of Rijeka research grant “Molecular features associated with BRAFV600E-mutated versus wild type BRAF colorectal cancer” (2019-2022). She is also the PI of the project No. 3238 - EPIC-XS 012: “Proteomic analysis of acquired resistance to vemurafenib in BRAF V600E–mutant colon cancer cells” (2019 - 2022) in collaboration with the Functional Genomics Center Zurich in Switzerland.

Rajesh Kumar Singh

Dr. Rajesh Kumar Singh received his BPharm (2003) and MPharm (2005) from UIPS, Panjab University, Chandigarh. He started to teach pharmaceutical chemistry at the Shivalik College of Pharmacy, Nangal, in 2006, where he completed his PhD in 2013 from IKG Punjab Technical University (IKGPTU), Jalandhar. His major areas of research interest are computer-aided drug-design, polymer-drug conjugates for targeted delivery to CNS and cancerous cells, antimalarial therapeutic agents, and green chemistry approaches for chemical synthesis. Dr. Singh has over 15 years of teaching experience and has guided one 03 Ph.D. and 20 PG students. He is currently guiding 02 PhDs and 02 MPharm students. He has published more than 70 peer-reviewed SCI/SCOPUS-indexed scientific papers with a total JCR Impact Factor of more than 200 in various chemistry and pharmacy journals such as European Journal of Medicinal Chemistry, Acta Pharmaceutica Sinica-B, Bioorganic Chemistry, Biomedicine and Pharmacotherapy, Pharmaceutical Research, European Journal of Pharmaceutical Sciences, Mini-Reviews in Medicinal Chemistry, Pharmaceutical Research, Med. Chem. Res., J. Enzyme Inhi. Med Chem., Res. Chem. Intermediate etc as main or corresponding author. He currently serves as an Editorial Advisory Board Member of 10 international journals, including the SCI-indexed MRMC (Bentham) and PeerJ. He has received the Publon Award 2016, 2017 and the Publon "Excellent Peer Reviewer Award" for outstanding reviewing of more than 290 research papers in different international journals of ACS, RSC, Springer, Elsevier, Dove, Informa, and Bentham whose Impact Factor varies from 1.0 to 12.5. He also has over 60 National and International Conference Abstracts, 5 Books, 5 Best Paper Presentation Awards, 1 Travel Grant to attend International Conferences, and 5 Research Projects funded by Indian Government Agencies. He is also on the panel of international reviewers for research proposals for Royal Society Grants. He is also serving as a PUBLON ACADEMY MENTOR and a BENTHAM BRAND AMBASSADOR. He has been recognized by the Editors as an OUTSTANDING REVIEWER for RSC Medicinal Chemistry journal (IF 4.1, Q1) and also for BENTHAM PUBLISHER in 2023. His name is recently featured in the list of top 2% scientists (2023) ranked by team of Stanford University, USA and Elsevier.

Srinivas Sistla

Dr. Srinivas Sistla is Director of Laboratories within the Microbiology and Immunology Department at State University of New York (SUNY) Stony Brook. He is a trained Biophysics and Drug Discovery Scientist, with experience working for industry and academia.

Dr. Sistla obtained his PhD in 2008 (Biotechnology and Biophysics) and is interested in the following fields of research; Bioactive Peptides, Biochemistry, Biophysics, Medical Biochemistry and Metabolomics, and Surface Plasmon Resonance.

Mansour Sobeh

Mansour Sobeh holds a B.Sc. in Chemistry from Ain Shams University, Egypt, an M.Sc. in Analytical Chemistry from the German University in Cairo, Egypt, and a Ph.D. in Natural Sciences (Dr. rer. nat.) from Heidelberg University, Germany. He is currently an Assistant Professor at Mohammed VI Polytechnic University

Dunxian Tan

Assistant professor/research at the University of Texas health Science Center at San Antonio USA. Associate Editor in Chief of the Journal of Pineal Research.

Duangjai Tungmunnithum

Assoc. Prof. Dr. Duangjai Tungmunnithum completed her Ph.D. at Chulalongkorn University in 2016, and won the DPST Postdoctoral Fellowship to conduct her Postdoctoral research in Japan at the National Museum of Nature and Science focusing on medicinal plant and phytochemistry in the same year. After completing her research in Japan, she obtained a lecturer position at the Faculty of Pharmacy, Mahidol University, Thailand.

Her expertise is in biochemistry, innovative green extraction methods, biological activity both antioxidant and anti-aging from plant extracts and pure phytochemical compounds for cosmetic and pharmaceutical applications both in vitro, in vivo and in cellulo models.

According to her research profiles, she has received a large number of outstanding research both national and international levels e.g. the Junior Research Fellowship from French Government, Franco-Thai Mobility Programme 2020-2021 and LE STUDIUM Research Fellowship.

Rohit Upadhyay

Dr. Rohit Upadhyay is a Research Scientist in the School of Medicine at Tulane University.

He has skills and expertise in the following areas; Cancer Genetics, Cell and Molecular biology, Kidney Injury, Pharmacology, and Molecular mechanisms of complex diseases.

David Vauzour

Dr David VAUZOUR received his PhD from the University of Montpellier (France) in 2004. His research, based at the University of Reading (2005-2011), and at the Norwich Medical School, University of East Anglia, UK (2011- present), has focused on investigating the molecular mechanisms that underlie the accumulating body of epidemiological, and medical evidence, on a positive correlation between the consumption of diets rich in fruits and vegetables and a decreased risk of (neuro)degenerative disorders. In this context, his initial work provided considerable insights into the potential for natural products to promote human vascular function, decrease (neuro)inflammation, enhance memory, learning and neuro-cognitive performances and to slow the progression of Alzheimer’s and Parkinson’s diseases. His recent interests concern how phytochemicals modulate ApoE genotype-induced cardiovascular risk and neurodegenerative disorders and their underlying mechanisms. Dr Vauzour sits on the board committee of “Groupe Polyphenols” and is the Co-Chair of the ILSI Europe “Nutrition and Mental Performance Task Force“.

Ranjit Vijayan

Dr. Ranjit Vijayan obtained his PhD in Life Sciences Interface/Biochemistry from the University of Oxford, UK, and his DipGrad in Management from the London School of Economics & Political Science, University of London, UK. In 2004 Dr Vijayan obtained his MSc in Computer Science from the University of Wales, Aberystwyth, UK, and prior to this his BEng in Electrical & Electronic Engineering, Nanyang Technological University, Singapore.

Dr. Vijayan's research interests include; molecular dynamics simulations of biological macromolecules, protein structure modeling, structure based drug discovery, genomics & transcriptomics, pharmacogenomics and high-performance computing.

Shibiao Wan

Dr. Shibiao Wan is currently an Assistant Professor in the Department of Genetics, Cell Biology and Anatomy, and the Co-Director for the Bioinformatics and Systems Biology (BISB) PhD Program at University of Nebraska Medical Center (UNMC). He is also an Assistant Professor (courtesy) in the Department of Biostatistics at UNMC.

With more than 15 years of experience in machine learning, bioinformatics, and computational biology, Dr. Wan has published >50 articles in top-tiered journals such as Genome Research, Nature Communications, Science Advances, Circulation Research, Briefings in Bioinformatics, and Bioinformatics. Dr. Wan is the Editor-in-Chief for Current Proteomics, and an Editorial Board Member for a series of prestigious journals such as Briefings in Functional Genomics, Heliyon, BMC Bioinformatics, International Journal of Microbiology, PeerJ Computer Science, BioMed Research International, and Computational and Mathematical Methods, and a guest associate editor for multiple high-impact journals including Frontiers in Immunology, Frontiers in Cell and Developmental Biology, Frontiers in Pharmacology, Biology, Frontiers in Genetics, and Genes.

Dr Wan is a TPC member for >20 machine learning related international conferences including IEEE ICTAI. Dr. Wan is also a reviewer for >70 prestigious journals including Nature Biotechnology, Nature Methods, Nature Communications, Nature Computational Science, Science Advances, Nucleic Acids Research, Advanced Science, Cancer Research, Genome Biology, and Genome Medicine. Dr. Wan has received a number of accolades including the Springer Nature Editor of Distinction Award in 2025 by Springer Nature, the New Investigator Award in 2024 by UNMC, the FIRST Award in 2023 by Nebraska EPSCoR, the Outstanding Young Alumni Award in 2022 by HK PolyU as well as the Global Peer Review Awards (top 1%) in “Cross-Field” and “Biology and Biochemistry” in 2019 by Clarivate. Dr. Wan is a member of AACR, ISCB and ACM and an IEEE Senior Member.

Xiaohui Wang

Principal Investigator of Chemical Biology Laboratory, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences
Council Member of Asian Pacific Society for Neurochemistry
Recipient of CAS Pioneer Hundred Talents Program
Recipient of the Migraine Research Foundation Award
Member of the Chinese Pharmaceutical Association (CPA)
Recipient of the Sanofi Award for Young Scientists in Bio-medicine
Recipient of the ISN -CAEN Award
Recipient of the APSN Young Investigator Award
Recipeint of the ISN-ESN Young Investigator Award

Principal Investigator (Professor) Xiaohui Wang received his B.Eng. degree (Bioengineering) in 2004 from Beijing Technology and Business University. He got his PhD degree in Chemical Biology in 2010 from Changchun Institute of Applied Chemistry, Chinese Academy of Sciences (CAS) under the supervision of Prof. Xiaogang Qu. He was co-mentored by Associate Prof. Hang (Hubert) Yin (Department of Chemistry and Biochemistry and the BioFrontiers Institute) and Distinguished Prof. Linda R. Watkins (Department of Psychology and Neuroscience and the Center for Neuroscience) at the University of Colorado at Boulder during his Post-Doc training. Since 2015, he starts his independent academic career.

Benjamin J. Whalley

Senior Lecturer in Pharmacology, University of Reading. British Neuroscience Association Local Group Representative. British Pharmacological Society (Member). UK Epilepsy Research Network (Interventions & Therapies CWG). Pharmacist (GPhC registered).

Investigating unmet clinical need in epilepsy with a specific focus on cannabinoid pharmacology using preclinical animal models and electrophysiological techniques supported by convention molecular and biochemical approaches.